Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sangamo Therapeutics
Biotech
Astellas pays Sangamo $20M to boost neurological gene therapies
Astellas continues to strengthen its neurological gene therapy capabilities, handing Sangamo $20 million upfront to bypass the blood-brain barrier.
James Waldron
Dec 19, 2024 7:13am
Sangamo slashes time to market for Fabry gene therapy
Oct 22, 2024 12:57pm
Genentech offers Sangamo $2B+ biobucks in neuro licensing deal
Aug 6, 2024 8:05am
Another Biogen exec hitches ride to Voyager —Chutes & Ladders
Mar 15, 2024 9:30am
Longtime BioMarin CEO hands off baton—Chutes & Ladders
Nov 3, 2023 9:30am
Rani and Sangamo jettison staff, assets to keep afloat next year
Nov 2, 2023 8:25am
